↓ Skip to main content

Lower starting dose of afatinib for the treatment of metastatic lung adenocarcinoma harboring exon 21 and exon 19 mutations

Overview of attention for article published in BMC Cancer, May 2021
Altmetric Badge

Mentioned by

twitter
2 tweeters

Readers on

mendeley
1 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Lower starting dose of afatinib for the treatment of metastatic lung adenocarcinoma harboring exon 21 and exon 19 mutations
Published in
BMC Cancer, May 2021
DOI 10.1186/s12885-021-08235-3
Pubmed ID
Authors

Chen, Yi-Chieh, Tsai, Ming-Ju, Lee, Mei-Hsuan, Kuo, Chia-Yu, Shen, Mei-Chiou, Tsai, Ying-Ming, Chen, Huang-Chi, Hung, Jen-Yu, Huang, Ming-Shyan, Chong, Inn-Wen, Yang, Chih-Jen

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 1 Mendeley reader of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 1 100%

Demographic breakdown

Readers by professional status Count As %
Librarian 1 100%
Readers by discipline Count As %
Nursing and Health Professions 1 100%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 May 2021.
All research outputs
#14,266,557
of 17,873,421 outputs
Outputs from BMC Cancer
#4,166
of 6,567 outputs
Outputs of similar age
#191,144
of 272,322 outputs
Outputs of similar age from BMC Cancer
#1
of 1 outputs
Altmetric has tracked 17,873,421 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,567 research outputs from this source. They receive a mean Attention Score of 4.1. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 272,322 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them